mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |